tirzepatide is insulin Major physiological roles of GLP-1 and GIP. acting as an Tirzepatide Mechanism of Weight Loss

Exposure to extreme temperatures can negatively impact the medications effectiveness and safety

Of 5111 respondents, approximately 61% of Medicare-eligible adults had a BMI of 27 or more, making them potentially eligible for semaglutide

Because of its structural differences, IGF-1 LR3 shows reduced affinity for certain IGF-binding proteins (IGFBPs) in vitro, enabling researchers to study more sustained receptor engagement and downstream signaling under controlled conditions

Last reviewed: June 4, 2026 Last updated: June 4, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Novo Nordisks drug Wegovy is FDA-approved for weight loss in adults, while the companys drug Ozempic is approved to treat diabetes but is also prescribed off-label for weight loss

It is a dual agonist, activating both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 (glucagon-like peptide-1) receptor simultaneously